Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sven Bruijns"'
Autor:
James Gallant, Tiaan Heunis, Caroline Beltran, Karin Schildermans, Sven Bruijns, Inge Mertens, Wilbert Bitter, Samantha L. Sampson
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
It was previously shown that secretion of PE-PGRS and PPE-MPTR proteins is abolished in clinical M. tuberculosis isolates with a deletion in the ppe38-71 operon, which is associated with increased virulence. Here we investigate the proteins dependent
Externí odkaz:
https://doaj.org/article/42db7efd661d44a59eea153e178e7947
Autor:
Dorian A. Stolk, Aram de Haas, Jana Vree, Sanne Duinkerken, Joyce Lübbers, Rieneke van de Ven, Martino Ambrosini, Hakan Kalay, Sven Bruijns, Hans J. van der Vliet, Tanja D. de Gruijl, Yvette van Kooyk
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
In this study we developed a liposome-based vaccine containing palmitoylated synthetic long peptides (SLP) and alpha galactosylceramide (αGC) to specifically target dendritic cells (DC) for activation of both innate (invariant natural killer T-cells
Externí odkaz:
https://doaj.org/article/c34750f04c244109b186f6110b88e981
Autor:
Oscar Pontesilli, Debby van Riel, Robert A. de Man, Sven Bruijns, Jon D. Laman, Fons G. C. M. Uytdehaag, Andeltje B. Van Nunen, Albert D. M. E. Osterhaus, Patrizia Carotenuto, Pieter E. Zondervan, Andre Artsen
Publikováno v:
Antimicrobial Agents & Chemotherapy, 49(2), 590-599. American Society for Microbiology
To investigate whether therapy with alpha interferon (IFN-α) induces changes in intrahepatic antigen-presenting cells (APCs), we obtained liver biopsy specimens before, during, and after therapy with IFN-α from chronic hepatitis B patients whose vi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d727ede85e53b0177572c477c5feecaa
https://doi.org/10.1128/aac.49.2.590-599.2005
https://doi.org/10.1128/aac.49.2.590-599.2005
Autor:
Martine Boks, Astrid van Beelen, Cynthia Fehres, Sven Bruijns, Martino Ambrosini, Hakan Kalay, Wendy Unger, Yvette van Kooyk
Publikováno v:
The Journal of Immunology. 190:170.7-170.7
Cancer immunotherapy requires potent tumor-specific T cell responses, initiated by dendritic cells (DCs). Our aim is to develop a therapy that specifically targets DCs in vivo in human skin using glycosylated liposomes that contain tumor antigen and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::01848bed28077451efdf8a53028bf7ba
https://doi.org/10.4049/jimmunol.190.supp.170.7
https://doi.org/10.4049/jimmunol.190.supp.170.7